Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-12

AUTHORS

Per-Göran Larsson, Babill Stray-Pedersen, Kjeld R Ryttig, Stig Larsen

ABSTRACT

BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure. METHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial. RESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding "Time from cure to relapse" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05) CONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up. TRIAL REGISTRATION NUMBER: ISRCTN62879834. More... »

PAGES

3

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1472-6874-8-3

DOI

http://dx.doi.org/10.1186/1472-6874-8-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005792714

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18197974


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Intravaginal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clindamycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Confidence Intervals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactobacillus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norway", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Odds Ratio", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Probiotics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Secondary Prevention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vagina", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaginosis, Bacterial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Women's Health", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Obstetrics and Gynaecology, K\u00e4rnsjukhuset, SE-541 85, Sk\u00f6vde, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larsson", 
        "givenName": "Per-G\u00f6ran", 
        "id": "sg:person.012634564012.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012634564012.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Obstetrics and Gynaecology, University of Oslo, Norway Rikshospitalet/Radiumhospitalet, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stray-Pedersen", 
        "givenName": "Babill", 
        "id": "sg:person.0631122174.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631122174.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Farmaservice, DK-2990, Niv\u00e5, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ryttig", 
        "givenName": "Kjeld R", 
        "id": "sg:person.010725643124.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725643124.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norwegian University of Life Sciences", 
          "id": "https://www.grid.ac/institutes/grid.19477.3c", 
          "name": [
            "Norwegian School of Veterinary Science, also Ullev\u00e5l University Hospital, Oslo, Norway"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larsen", 
        "givenName": "Stig", 
        "id": "sg:person.013272512512.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013272512512.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ajog.2005.11.041", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003579888"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005630776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005630776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007778437"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(83)91112-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008512415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.78.6.413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019639706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.78.6.413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019639706"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.2003.006106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023980654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/sti.2003.006106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023980654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0463.2005.apm_01.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029477183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1471-0528.2006.00946.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032365488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/503780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034159474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007435-199205000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037521551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007435-199205000-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037521551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-8244(02)00465-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038163667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jcm.40.8.2746-2749.2002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046109635"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.micinf.2006.01.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049637601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00015550410022249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058255052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.308.6924.295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062767566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.308.6924.295", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062767566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074813072", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076994697", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077230119", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077315051", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078295192", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-12", 
    "datePublishedReg": "2008-12-01", 
    "description": "BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure.\nMETHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial.\nRESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding \"Time from cure to relapse\" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05)\nCONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up.\nTRIAL REGISTRATION NUMBER: ISRCTN62879834.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1472-6874-8-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028438", 
        "issn": [
          "1472-6874"
        ], 
        "name": "BMC Women's Health", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study", 
    "pagination": "3", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1b98de490012b06853822103fc1ed5efce600e3c72bcee547156f55fd2eb102e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18197974"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088690"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1472-6874-8-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005792714"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1472-6874-8-3", 
      "https://app.dimensions.ai/details/publication/pub.1005792714"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1472-6874-8-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1472-6874-8-3'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      21 PREDICATES      69 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1472-6874-8-3 schema:about N0371e956fee14466b37705baff677060
2 N13aa40bba10e4444bb7da3cf012be1f2
3 N165f77dbb039492db3bbc40a167576f5
4 N21bfba2a71fe4323a81aa9c05955680d
5 N28ebff88eb71420b8f0a58bf32049aef
6 N2db37944b46a45d7987f3fd862b25f1c
7 N327137fca576441da4b80780600b42fb
8 N37b6e9e237fa44e8a7a9e5d663976345
9 N3c4d222304b6481e8ee692f49d9ed953
10 N3e69f1a83bc94b92a94243d862031795
11 N72cc1b129432491991e16a8fbb445d4c
12 N8bfc86cd29264e9a9246bc2b826eb65c
13 N925e56895237449faa48920c8c37717f
14 N9938c64905af4862915e668a499c85cc
15 Nbf00947973664be584d58179679aec29
16 Nd7e47f88dd8a46f488b006a4b41cc321
17 Ne202c99f2a1146da883f5a30f7c9d5b7
18 Ne4858452c612431a8da4e4a6531041b7
19 Ne78bcc7acd9e45fa8fe079c131f36900
20 Nf24d4bec7dd04879a2b482dfd6b76ea0
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author Nd5f0efa96d7143e68dbb68768dd485d4
24 schema:citation https://app.dimensions.ai/details/publication/pub.1074813072
25 https://app.dimensions.ai/details/publication/pub.1076994697
26 https://app.dimensions.ai/details/publication/pub.1077230119
27 https://app.dimensions.ai/details/publication/pub.1077315051
28 https://app.dimensions.ai/details/publication/pub.1078295192
29 https://doi.org/10.1016/0002-9343(83)91112-9
30 https://doi.org/10.1016/j.ajog.2005.11.041
31 https://doi.org/10.1016/j.micinf.2006.01.003
32 https://doi.org/10.1016/s0928-8244(02)00465-0
33 https://doi.org/10.1080/00015550410022249
34 https://doi.org/10.1086/503780
35 https://doi.org/10.1097/00007435-199205000-00007
36 https://doi.org/10.1111/j.1471-0528.2006.00946.x
37 https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x
38 https://doi.org/10.1111/j.1600-0463.2005.apm_01.x
39 https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x
40 https://doi.org/10.1128/jcm.40.8.2746-2749.2002
41 https://doi.org/10.1136/bmj.308.6924.295
42 https://doi.org/10.1136/sti.2003.006106
43 https://doi.org/10.1136/sti.78.6.413
44 schema:datePublished 2008-12
45 schema:datePublishedReg 2008-12-01
46 schema:description BACKGROUND: The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during 3 menstrual cycles could lengthen the time to relapse after initial cure. METHODS: Women (n = 100) with bacterial vaginosis diagnosed by Amsel criteria were after informed consent offered vaginal clindamycin therapy followed by vaginal gelatine capsules containing either 109 freeze-dried lactobacilli or identical placebo capsules for 10 days during 3 menstrual cycles in a double-blind, randomized, placebo-controlled trial. RESULTS: The initial intent to treat (ITT) analysis for the one-month cure rate was 64% in the lactobacilli group and 78% in the placebo group (p > 0.05). However, any patient with missing or unclassified smears at the initial visit who continued the study and whose next smear indicated a cure was included in the cured group; the study also excluded two of the patients in the lactobacilli group who reported that they did not take any vaginal capsules. With consideration to these population changes, the initial cure rate would be 77% in the lactobacilli group. The 76 cured women were followed for 6 menstrual cycles or until relapse within that time span. At the end of the study, 64.9% (24/37) of the lactobacilli treated women were still BV-free compared to 46.2% (18/39) of the placebo treated women. Comparison of the two groups regarding "Time from cure to relapse" was statistically significant (p = 0.027) in favour of the lactobacilli treatment. Adjuvant therapy with lactobacilli contributed significantly to avoidance of relapse with a proportional Hazard Risk ratio (HR) of 0.73 (0.54-0.98) (p < 0.05) CONCLUSION: The study shows that supplementary treatment combining two different strains of probiotic lactobacilli does not improve the efficacy of BV therapy during the first month of treatment, but for women initially cured, adjunct treatment of lactobacilli during 3 menstrual cycles lengthens the time to relapse significantly in that more women remained BV free at the end of the 6-month follow up. TRIAL REGISTRATION NUMBER: ISRCTN62879834.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree true
50 schema:isPartOf N3dea34fc7f684aa28e597286cc5e5953
51 Na80b6bb25b3c408790a104bb93073c3d
52 sg:journal.1028438
53 schema:name Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
54 schema:pagination 3
55 schema:productId N6006584e9bc94241a0761f8b75940d96
56 N7603bd77c699425d927a076e85b0cc18
57 N93a3e6fa455c4cbcbf8b0cc6e61d6bc5
58 Nb6721ba7a6564d79ab92baf88efc5f9d
59 Nee9e10c110dd418d83ec48ba53647e04
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005792714
61 https://doi.org/10.1186/1472-6874-8-3
62 schema:sdDatePublished 2019-04-10T19:08
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N8da22e40a8014790ab652b06e86e9567
65 schema:url http://link.springer.com/10.1186%2F1472-6874-8-3
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N0371e956fee14466b37705baff677060 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Odds Ratio
71 rdf:type schema:DefinedTerm
72 N13aa40bba10e4444bb7da3cf012be1f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Combined Modality Therapy
74 rdf:type schema:DefinedTerm
75 N165f77dbb039492db3bbc40a167576f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Vaginosis, Bacterial
77 rdf:type schema:DefinedTerm
78 N21bfba2a71fe4323a81aa9c05955680d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Confidence Intervals
80 rdf:type schema:DefinedTerm
81 N28ebff88eb71420b8f0a58bf32049aef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Norway
83 rdf:type schema:DefinedTerm
84 N2db37944b46a45d7987f3fd862b25f1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Secondary Prevention
86 rdf:type schema:DefinedTerm
87 N327137fca576441da4b80780600b42fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Administration, Oral
89 rdf:type schema:DefinedTerm
90 N37b6e9e237fa44e8a7a9e5d663976345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Adult
92 rdf:type schema:DefinedTerm
93 N3c4d222304b6481e8ee692f49d9ed953 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Double-Blind Method
95 rdf:type schema:DefinedTerm
96 N3dea34fc7f684aa28e597286cc5e5953 schema:volumeNumber 8
97 rdf:type schema:PublicationVolume
98 N3e69f1a83bc94b92a94243d862031795 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Women's Health
100 rdf:type schema:DefinedTerm
101 N4f0f9c258af64436b14657b59e97cb8f rdf:first sg:person.010725643124.05
102 rdf:rest Nd18da6c1fac743f399992727f0dc73fa
103 N6006584e9bc94241a0761f8b75940d96 schema:name pubmed_id
104 schema:value 18197974
105 rdf:type schema:PropertyValue
106 N6a49181c7cc64ad5a882aa259bff68c3 schema:name Department of Obstetrics and Gynaecology, Kärnsjukhuset, SE-541 85, Skövde, Sweden
107 rdf:type schema:Organization
108 N72cc1b129432491991e16a8fbb445d4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Female
110 rdf:type schema:DefinedTerm
111 N7603bd77c699425d927a076e85b0cc18 schema:name dimensions_id
112 schema:value pub.1005792714
113 rdf:type schema:PropertyValue
114 N8bfc86cd29264e9a9246bc2b826eb65c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Lactobacillus
116 rdf:type schema:DefinedTerm
117 N8da22e40a8014790ab652b06e86e9567 schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 N925e56895237449faa48920c8c37717f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Anti-Bacterial Agents
121 rdf:type schema:DefinedTerm
122 N93a3e6fa455c4cbcbf8b0cc6e61d6bc5 schema:name doi
123 schema:value 10.1186/1472-6874-8-3
124 rdf:type schema:PropertyValue
125 N964ff25ce74f4bd98e512f57d69009a0 schema:name Department of Obstetrics and Gynaecology, University of Oslo, Norway Rikshospitalet/Radiumhospitalet, Oslo, Norway
126 rdf:type schema:Organization
127 N9938c64905af4862915e668a499c85cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Probiotics
129 rdf:type schema:DefinedTerm
130 Na80b6bb25b3c408790a104bb93073c3d schema:issueNumber 1
131 rdf:type schema:PublicationIssue
132 Nb6721ba7a6564d79ab92baf88efc5f9d schema:name nlm_unique_id
133 schema:value 101088690
134 rdf:type schema:PropertyValue
135 Nbf00947973664be584d58179679aec29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Humans
137 rdf:type schema:DefinedTerm
138 Ncd61d27b25524d0f930852404d43afeb rdf:first sg:person.0631122174.01
139 rdf:rest N4f0f9c258af64436b14657b59e97cb8f
140 Nd18da6c1fac743f399992727f0dc73fa rdf:first sg:person.013272512512.34
141 rdf:rest rdf:nil
142 Nd5749813275f4ee493e6009b436516b9 schema:name Farmaservice, DK-2990, Nivå, Denmark
143 rdf:type schema:Organization
144 Nd5f0efa96d7143e68dbb68768dd485d4 rdf:first sg:person.012634564012.84
145 rdf:rest Ncd61d27b25524d0f930852404d43afeb
146 Nd7e47f88dd8a46f488b006a4b41cc321 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Middle Aged
148 rdf:type schema:DefinedTerm
149 Ne202c99f2a1146da883f5a30f7c9d5b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Clindamycin
151 rdf:type schema:DefinedTerm
152 Ne4858452c612431a8da4e4a6531041b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Follow-Up Studies
154 rdf:type schema:DefinedTerm
155 Ne78bcc7acd9e45fa8fe079c131f36900 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Administration, Intravaginal
157 rdf:type schema:DefinedTerm
158 Nee9e10c110dd418d83ec48ba53647e04 schema:name readcube_id
159 schema:value 1b98de490012b06853822103fc1ed5efce600e3c72bcee547156f55fd2eb102e
160 rdf:type schema:PropertyValue
161 Nf24d4bec7dd04879a2b482dfd6b76ea0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Vagina
163 rdf:type schema:DefinedTerm
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
168 schema:name Clinical Sciences
169 rdf:type schema:DefinedTerm
170 sg:journal.1028438 schema:issn 1472-6874
171 schema:name BMC Women's Health
172 rdf:type schema:Periodical
173 sg:person.010725643124.05 schema:affiliation Nd5749813275f4ee493e6009b436516b9
174 schema:familyName Ryttig
175 schema:givenName Kjeld R
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010725643124.05
177 rdf:type schema:Person
178 sg:person.012634564012.84 schema:affiliation N6a49181c7cc64ad5a882aa259bff68c3
179 schema:familyName Larsson
180 schema:givenName Per-Göran
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012634564012.84
182 rdf:type schema:Person
183 sg:person.013272512512.34 schema:affiliation https://www.grid.ac/institutes/grid.19477.3c
184 schema:familyName Larsen
185 schema:givenName Stig
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013272512512.34
187 rdf:type schema:Person
188 sg:person.0631122174.01 schema:affiliation N964ff25ce74f4bd98e512f57d69009a0
189 schema:familyName Stray-Pedersen
190 schema:givenName Babill
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631122174.01
192 rdf:type schema:Person
193 https://app.dimensions.ai/details/publication/pub.1074813072 schema:CreativeWork
194 https://app.dimensions.ai/details/publication/pub.1076994697 schema:CreativeWork
195 https://app.dimensions.ai/details/publication/pub.1077230119 schema:CreativeWork
196 https://app.dimensions.ai/details/publication/pub.1077315051 schema:CreativeWork
197 https://app.dimensions.ai/details/publication/pub.1078295192 schema:CreativeWork
198 https://doi.org/10.1016/0002-9343(83)91112-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008512415
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.ajog.2005.11.041 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003579888
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.micinf.2006.01.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049637601
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0928-8244(02)00465-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038163667
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1080/00015550410022249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058255052
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1086/503780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034159474
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1097/00007435-199205000-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037521551
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1111/j.1471-0528.2006.00946.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032365488
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1111/j.1600-0463.2005.apm1130301.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007778437
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1111/j.1600-0463.2005.apm_01.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029477183
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1111/j.1600-0463.2005.apm_113501.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005630776
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1128/jcm.40.8.2746-2749.2002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046109635
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1136/bmj.308.6924.295 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062767566
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1136/sti.2003.006106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023980654
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1136/sti.78.6.413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019639706
227 rdf:type schema:CreativeWork
228 https://www.grid.ac/institutes/grid.19477.3c schema:alternateName Norwegian University of Life Sciences
229 schema:name Norwegian School of Veterinary Science, also Ullevål University Hospital, Oslo, Norway
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...